Pari Homepage

Results will be updated as you type

News, Publications & Insights

Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.

Digital illustration of lungs with connected data structures and technical graphics, featuring the eFlow® Technology logo.

Categories

  • PARI News
  • Partner News
  • PARI Publications
  • Publications
  • eFlow Integrated

Posts of category: Publications

Peer-reviewed research, clinical studies, and scientific papers related to eFlow® Technology and inhaled therapies.

Published
November 29, 2023
Category
  • Publications

Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial.

Published
November 8, 2023
Category
  • Publications

Mucosal Adenoviral-vectored Vaccine Boosting Durably Prevents XBB.1.16 Infection in Nonhuman Primates.

Published
November 3, 2023
Category
  • Publications

Aerosol delivery of SARS-CoV-2 human monoclonal antibodies in macaques limits viral replication and lung pathology.

Published
October 2, 2023
Category
  • Publications

Nebulization of PEGylated recombinant human deoxyribonuclease I using vibrating membrane nebulizers: A technical feasibility study.

Published
June 7, 2023
Category
  • Publications

Large-eddy simulation, convective instability, and modal causality of coaxial supersonic air–water jets considering a swirl effect.

Previous page
of 9
Next page

Back to overview

  1. eFlow Partnering
  2. News & Publications
  3. Categories
Link to PARI at LinkedIn
PARI Logo

+49 (0) 8151 279 279
 

Contact

  • Career
  • Press portal
  • Partner with us
  • PARI INT
  • Imprint
  • Data Protection
  • Cookie Consent
  • Accessibility Statement
  • General Terms and conditions

© 2026 PARI GmbH Spezialisten für effektive Inhalation